Research ArticleSystemic Lupus Erythematosus

The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms

Titilola Falasinnu, Cristina Drenkard, Gaobin Bao, Sean Mackey and S. Sam Lim
The Journal of Rheumatology August 2021, 48 (8) 1279-1289; DOI: https://doi.org/10.3899/jrheum.200595

REFERENCES

  1. 1.↵
    1. Dahlhamer JM,
    2. Lucas J,
    3. Zelaya C,
    4. Nahin R,
    5. Mackey S,
    6. Debar L, et al.
    Prevalence of chronic pain and high-impact chronic pain among adults — United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:1001-6.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Borenstein DG,
    2. Hassett AL,
    3. Pisetsky D.
    Pain management in rheumatology research, training, and practice. Clin Exp Rheumatol 2017;35 Suppl 107:2-7.
    OpenUrl
  3. 3.↵
    1. Lupus and Allied Diseases Association, Lupus Foundation of America, Lupus Research Alliance
    . Lupus: patient voices. Report on externally-led patient-focused drug development meeting: September 25, 2017. [Internet. Accessed March 16, 2021.] Available from: www.lupuspfdd.org/LupusPatientVoicesFINAL.pdf
  4. 4.↵
    1. Lee J,
    2. Lin J,
    3. Suter LG,
    4. Fraenkel L.
    Persistently frequent emergency department utilization among persons with systemic lupus erythematosus. Arthritis Care Res 2019;71:1410-8.
    OpenUrlPubMed
  5. 5.↵
    1. Pitcher MH,
    2. Von Korff M,
    3. Bushnell MC,
    4. Porter L.
    Prevalence and profile of high-impact chronic pain in the United States. J Pain 2019;20:146-60.
    OpenUrl
  6. 6.↵
    1. Grol-Prokopczyk H.
    Sociodemographic disparities in chronic pain, based on 12-year longitudinal data. Pain 2017;158:313-22.
    OpenUrlCrossRef
  7. 7.↵
    1. Meints SM,
    2. Edwards RR.
    Evaluating psychosocial contributions to chronic pain outcomes. Prog Neuropsychopharmacol 2018; 87:168-82.
    OpenUrl
  8. 8.↵
    1. Kim J,
    2. Ahn H,
    3. Lyon DE,
    4. Stechmiller J.
    Building a biopsychosocial conceptual framework to explore pressure ulcer pain for hospitalized patients. Healthcare 2016;4:7.
    OpenUrl
  9. 9.↵
    1. Drenkard C,
    2. Rask KJ,
    3. Easley KA,
    4. Bao G,
    5. Lim SS.
    Primary preventive services in patients with systemic lupus erythematosus: study from a population-based sample in Southeast U.S. Semin Arthritis Rheum 2013;43:209-16.
    OpenUrlPubMed
  10. 10.↵
    1. Karlson EW,
    2. Daltroy LH,
    3. Rivest C,
    4. Ramsey-Goldman R,
    5. Wright EA,
    6. Partridge AJ, et al.
    Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003; 12:280-6.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Yazdany J,
    2. Yelin EH,
    3. Panopalis P,
    4. Trupin L,
    5. Julian L,
    6. Katz PP.
    Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a large observational cohort. Arthritis Care Res 2008;59:136-43.
    OpenUrlCrossRef
  12. 12.↵
    1. Yazdany J,
    2. Trupin L,
    3. Gansky SA,
    4. Dall’era M,
    5. Yelin EH,
    6. Criswell LA, et al.
    Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus. Arthritis Care Res 2011;63:1170-7.
    OpenUrl
  13. 13.↵
    1. Katz P,
    2. Trupin L,
    3. Rush S,
    4. Yazdany J.
    Longitudinal validation of the brief index of lupus damage. Arthritis Care Res 2014;66:1057-62.
    OpenUrl
  14. 14.↵
    1. Jordan J,
    2. Thompson NJ,
    3. Dunlop-Thomas C,
    4. Lim SS,
    5. Drenkard C.
    Relationships among organ damage, social support, and depression in African American women with systemic lupus erythematosus. Lupus 2019;28:253-60.
    OpenUrlPubMed
  15. 15.↵
    1. Drenkard C,
    2. Bao G,
    3. Dennis G,
    4. Kan HJ,
    5. Jhingran PM,
    6. Molta CT, et al.
    Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States. Arthritis Care Res 2014;66:878-87.
    OpenUrlCrossRef
  16. 16.↵
    1. Amtmann D,
    2. Cook KF,
    3. Jensen MP,
    4. Chen WH,
    5. Choi S,
    6. Revicki D, et al.
    Development of a PROMIS item bank to measure pain interference. Pain 2010;150:173-82.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Schalet BD,
    2. Pilkonis PA,
    3. Yu L,
    4. Dodds N,
    5. Johnston KL,
    6. Yount S, et al.
    Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples. J Clin Epidemiol 2016;73:119-27.
    OpenUrl
  18. 18.↵
    1. Carver CS.
    You want to measure coping but your protocol’s too long: Consider the brief COPE. Int J Behav Med 1997;4:92-100.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Muller L,
    2. Spitz E.
    [Multidimensional assessment of coping: validation of the Brief COPE among French population]. [Article in French] Encephale 2003;29:507-18.
    OpenUrlPubMed
  20. 20.↵
    1. Hahn EA,
    2. Devellis RF,
    3. Bode RK,
    4. Garcia SF,
    5. Castel LD,
    6. Eisen SV, et al.
    Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res 2010;19:1035-44.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Barnes LL,
    2. Mendes De Leon CF,
    3. Wilson RS,
    4. Bienias JL,
    5. Bennett DA,
    6. Evans DA.
    Racial differences in perceived discrimination in a community population of older Blacks and Whites. J Aging Health 2004;16:315-37.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Brown C,
    2. Matthews KA,
    3. Bromberger JT,
    4. Chang Y.
    The relation between perceived unfair treatment and blood pressure in a racially/ethnically diverse sample of women. Am J Epidemiol 2006; 164:257-62.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Gee GC,
    2. Spencer MS,
    3. Chen J,
    4. Takeuchi D.
    A nationwide study of discrimination and chronic health conditions among Asian Americans. Am J Public Health 2007;97:1275-82.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Hunte HE,
    2. Williams DR.
    The association between perceived discrimination and obesity in a population-based multiracial and multiethnic adult sample. Am J Public Health 2009;99:1285-92.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Taylor TR,
    2. Kamarck TW,
    3. Shiffman S.
    Validation of the Detroit Area Study Discrimination Scale in a community sample of older African American adults: the Pittsburgh healthy heart project. Int J Behav Med 2004;11:88-94.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Cutrona CE,
    2. Russell DW,
    3. Abraham WT,
    4. Gardner KA,
    5. Melby JN,
    6. Bryant C, et al.
    Neighborhood context and financial strain as predictors of marital interaction and marital quality in African American couples. Pers Relatsh 2003;10:389-409.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Faul F,
    2. Buchner A,
    3. Erdfelder E,
    4. Mayr S.
    A short tutorial of GPower. Tutor Quant Methods Psychol 2007;3:51-9.
    OpenUrl
  28. 28.↵
    1. Fifield J,
    2. Reisine ST,
    3. Grady K.
    Work disability and the experience of pain and depression in rheumatoid arthritis. Soc Sci Med 1991;33:579-85.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Heitmann H,
    2. Haller B,
    3. Tiemann L,
    4. Mühlau M,
    5. Berthele A,
    6. Tölle TR, et al.
    Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. Pain 2020;161:787-96.
    OpenUrl
  30. 30.↵
    1. Day MA,
    2. Ehde DM,
    3. Ward LC,
    4. Hartoonian N,
    5. Alschuler KN,
    6. Turner AP, et al.
    An empirical investigation of a biopsychosocial model of pain in multiple sclerosis. Clin J Pain 2016;32:155-63.
    OpenUrl
  31. 31.↵
    1. Booker SQ,
    2. Sibille KT,
    3. Terry EL,
    4. Cardoso JS,
    5. Goodin BR,
    6. Sotolongo A, et al.
    Psychological predictors of perceived age and chronic pain impact in individuals with and without knee osteoarthritis. Clin J Pain 2020;36:569-77.
    OpenUrl
  32. 32.↵
    1. Schlenz AM,
    2. Schatz J,
    3. Roberts CW.
    Examining biopsychosocial factors in relation to multiple pain features in pediatric sickle cell disease. J Pediatr Psychol 2016;41:930-40.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Waldheim E,
    2. Elkan AC,
    3. Pettersson S,
    4. van Vollenhoven R,
    5. Bergman S,
    6. Frostegård J, et al.
    Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus 2013;22:1118-27.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Eudy AM,
    2. Vines AI,
    3. Dooley MA,
    4. Cooper GS,
    5. Parks CG.
    Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus. Lupus 2014;23:1460-7.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Greco CM,
    2. Rudy TE,
    3. Manzi S.
    Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory. Pain Med 2003;4:39-50.
    OpenUrl
  36. 36.↵
    1. Drenkard C,
    2. Lim SS.
    Update on lupus epidemiology: Advancing health disparities research through the study of minority populations. Curr Opin Rheumatol 2019;31:689-96.
    OpenUrl
  37. 37.↵
    1. Lim SS,
    2. Bayakly AR,
    3. Helmick CG,
    4. Gordon C,
    5. Easley KA,
    6. Drenkard C.
    The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry. Arthritis Rheumatol 2014;66:357-68.
    OpenUrlPubMed
  38. 38.↵
    1. Jolly M,
    2. Sequeira W,
    3. Block JA,
    4. Toloza S,
    5. Bertoli A,
    6. Blazevic I, et al.
    Sex differences in quality of life in patients with systemic lupus erythematosus. Arthritis Care Res 2019;71:1647-52.
    OpenUrl
  39. 39.↵
    1. Carter EE,
    2. Barr SG,
    3. Clarke AE.
    The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 2016;12:605-20.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Poleshuck EL,
    2. Green CR.
    Socioeconomic disadvantage and pain. Pain 2008;136:235-8.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Rizk A,
    2. Gheita TA,
    3. Nassef S,
    4. Abdallah A.
    The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Int J Rheum Dis 2012;15:261-7.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Patterson SL,
    2. Schmajuk G,
    3. Jafri K,
    4. Yazdany J,
    5. Katz P.
    Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus. Arthritis Care Res 2019;71:126-33.
    OpenUrl
  43. 43.↵
    1. Chaiamnuay S,
    2. Bertoli AM,
    3. Fernández M,
    4. Apte M,
    5. Vilá LM,
    6. Reveille JD, et al.
    The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol 2007;13:128-33.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Teh P,
    2. Zakhary B,
    3. Sandhu VK.
    The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR). Clin Rheumatol 2019;38:597-600.
    OpenUrl
  45. 45.↵
    1. Okifuji A,
    2. Hare BD.
    The association between chronic pain and obesity. J Pain Res 2015;8:399-408.
    OpenUrlPubMed
  46. 46.↵
    1. Lillis TA,
    2. Tirone V,
    3. Gandhi N,
    4. Weinberg S,
    5. Nika A,
    6. Sequeira W, et al.
    Sleep disturbance and depression symptoms mediate relationship between pain and cognitive dysfunction in lupus. Arthritis Care Res 2019;71:406-12.
    OpenUrl
  47. 47.↵
    1. Schmeding A,
    2. Schneider M.
    Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Clin Rheumatol 2013;27:363-75.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

BIOPSYCHOSOCIAL
DISEASE ACTIVITY
PAIN
social determinants of health
SYSTEMIC LUPUS ERYTHEMATOSUS

Keywords